DBXD 📈 Xtrackers - DAX UCITS - Overview

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0274211480 • Germany Equity

DBXD: German, Stocks, Equity, Index, Funds

‣ Company URL: http://www.dws.lu ‣ Domicile: Luxembourg ‣ Index Name: Morningstar Germany TME NR EUR

Additional Sources for DBXD ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

DBXD ETF Overview

Market Cap in USD 4,589m
Category Germany Equity
TER 0.09%
IPO / Inception 2007-01-10

DBXD ETF Ratings

Growth 5y 59.4%
Fundamental -
Dividend -
Rel. Strength Industry 0.6
Analysts -
Fair Price Momentum 183.56 EUR
Fair Price DCF -

DBXD Dividends

No Dividends Paid

DBXD Growth Ratios

Growth Correlation 3m 54.1%
Growth Correlation 12m 87.1%
Growth Correlation 5y 77.1%
CAGR 5y 7.76%
CAGR/Mean DD 5y 1.16
Sharpe Ratio 12m 1.07
Alpha -2.89
Beta 0.77
Volatility 10.30%
Current Volume 125.7k
Average Volume 20d 51.2k
What is the price of DBXD stocks?
As of December 21, 2024, the stock is trading at EUR 187.44 with a total of 125,661 shares traded.
Over the past week, the price has changed by -2.14%, over one month by +4.87%, over three months by +5.14% and over the past year by +18.79%.
Is Xtrackers - DAX UCITS a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Xtrackers - DAX UCITS (XETRA:DBXD) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 59.41 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DBXD as of December 2024 is 183.56. This means that DBXD is currently overvalued and has a potential downside of -2.07%.
Is DBXD a buy, sell or hold?
Xtrackers - DAX UCITS has no consensus analysts rating.
What are the forecast for DBXD stock price target?
According to ValueRays Forecast Model, DBXD Xtrackers - DAX UCITS will be worth about 202.7 in December 2025. The stock is currently trading at 187.44. This means that the stock has a potential upside of +8.11%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 202.7 8.1%